Legend Biotech Corporation
|Company Name||Legend Biotech Corporation|
On September 21, 2020, Legend disclosed that the Customs Anti-Smuggling Department of China inspected Legend Biotech’s location in Nanjing. According to Legend, the inspection was in connection with what Legend understands to be an investigation relating to suspected violations of import and export regulations under the laws of China.
On this news, Legend’s share price fell $4.50 per share, or 14%, to close at $27.50 per share on September 21, 2020, thereby injuring investors.
Submit Your Information
If you suffered a loss on your Legend Biotech Corporation investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.
An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.